FII selling spooks market; RIL, Infy down over 1%

Sensex slips 100 points as banks, oil and gas and IT heavyweights drag

SI Reporter Mumbai
Last Updated : Jan 07 2014 | 2:09 PM IST
Benchmark indices continue to remain under pressure as FIIs steeped up their selling in index futures. Also, weak Asian cues compounded the negative sentiment. 

At 1330 hrs, the Sensex was down 100 points at 20,687 and the Nifty gave off 32 points to trade at 6,159. The ones weighing on the indices were banks, oil and gas and IT heavyweights.

In the broader markets, the smallcap index was up 0.5%, outperforming the BSE benchmark index and the midcap index which were down 0.5% and 0.3% respectively.

Also Read

Foreign institutional investors (FIIs) sold shares worth a net Rs 318.91 crore on Monday as per provisional data from the stock exchanges.

Adds Mudit Goyal, technical analyst, SMC Global, “Technically, Nifty has given the breakdown of upward sloping resistance line and also manages to close below the same. So, more downside can be witnessed in coming days upto 6100 levels and on the upper side, 6250 is near term resistance mark.”   

All the sectoral indices except, Capital goods, Auto and Health Care indices were in the positive territory, up 0.1-0.6%.

Bankex, Realty, Power, Oil & Gas and Metal indices were down 1-2%.

Maruti Suzuki, Mahindra & Mahindra and Tata Motors up 0.2-2% were among the gainers from the auto space in Sensex-30.

Sun Pharma, BHEL, Dr Reddys Lab, L&T and Bharti Airtel which added 0.2-1.3% rounded off the gainers list.

Tata Power and Tata Steel down 3% each were the top losers followed by Tata Steel and Hindalco down 2% each.

ONGC, NTPC, SBI, Sesa Sterlite, Reliance Industries, ICICI Bank, RIL were the other prominent losers, down between 1-2%.

Frontline IT names were weak ahead of Infosys quarterly numbers with TCS, Infosys and Wipro losing 0.6-1.5%.

In other stocks, Financial Technologies India (FTIL) was locked in upper circuit of 10% at Rs 271, also its highest level since August, with no sellers are seen on the counter in otherwise weak market.

Zuari Agro Chemicals soared 8% to Rs 162, extending its previous day’s 5% rally, on reports that Zuari Fertilisers & Chemicals is planning to divest its entire stake in Mangalore Chemicals and Fertilizers.

Sharon Bio-Medicine has rallied 7% to Rs 435, extending its previous day’s 10% surge, after the mid-sized pharmaceutical company announced bonus issue and sub division of equity shares.

Market breadth was marginally negative on the BSE. 1,151 stocks declined while 1,147 stocks advanced.

Weak Asian cues

Asian shares fell to a near four-month low on Tuesday, though the dollar rebounded after overnight weakness on disappointing US services sector data that raised concerns about stuttering growth in the world's largest economy.

MSCI's broadest index of Asia-Pacific shares outside Japan eased 0.3%, heading for a fifth straight day of losses.

Japan's Nikkei index shed 0.6%, adding to a 2.4% slide on Monday.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 07 2014 | 1:58 PM IST

Next Story